ARM 37.106.3305

ARM 37.106.3305. APPLICATION AND LICENSING

Last amended: 2026Length: 207 wordsOfficial source

Cite as Mont. Admin. R. 37.106.3305

(1) In addition to the requirements set forth in 50-5-203, MCA, each application for an experimental treatment center must include: (a) the name of the medical director of the experimental treatment center; (b) the qualifications of the administrator, medical director, and all professional staff; (c) the disclosures regarding: (i) whether the applicant, owner, or affiliate has operated a health care facility that was closed as a direct result of issues of patient health and safety; (ii) whether the owner or any clinic staff has been convicted of a felony offense; and (iii) whether the owner or any clinic staff was ever employed by a facility owned or operated by the applicant that was closed because of administrative or legal action; (d) the general types of experimental treatments the center intends to perform or provide; (e) an attestation that the applicant is of reputable and responsible character, including demonstrating accountability and reliably fulfilling commitments, and is able to comply with all rules applicable to experimental treatment centers; and (f) an explanation of how the experimental treatment center will fulfill the health freedom and access requirement pursuant to 50-5-251, MCA. (2) Pursuant to 50-5-201(2), MCA, upon a change of ownership, a new owner must apply for a new license.
ARM 37.106.3305: ARM 37.106.3305. APPLICATION AND LICENSING | Justis AI